CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers.

Saved in:
Bibliographic Details
Title: CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers.
Authors: Jung HR; Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Korea.; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Korea., Oh Y; Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Korea.; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Korea., Na D; Ewha Institute of Convergence Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea., Min S; Department of Life Science, Ewha Womans University, Seoul, Korea., Kang J; Department of Life Science, Ewha Womans University, Seoul, Korea., Jang D; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea., Shin S; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea., Kim J; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea., Lee SE; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea., Jeong EM; Department of Pharmacy, College of Pharmacy, Jeju National University, Jeju Special Self-Governing Province, Korea.; Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju Special Self-Governing Province, Korea.; Bio-Health Materials Core-Facility Center, Jeju National University, Jeju Special Self-Governing Province, Korea.; Practical Translational Research Center, Jeju National University, Jeju Special Self-Governing Province, Korea., An JY; School of Biosystem and Biomedical Science, College of Health Science, Korea University, Seoul, Korea., Sung CO; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Lee WS; Department of Surgery, Gil Medical Center, Gachon University, Incheon, Korea., Lee C; Department of Life Science, Ewha Womans University, Seoul, Korea.; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Cho SY; Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Korea. csybio@snu.ac.kr.; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea. csybio@snu.ac.kr.; Cancer Research Institute, Seoul National University, Seoul, Korea. csybio@snu.ac.kr.
Source: Oncogene [Oncogene] 2021 May; Vol. 40 (18), pp. 3287-3302. Date of Electronic Publication: 2021 Apr 12.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene
Database: MEDLINE Ultimate
Description
ISSN:1476-5594
DOI:10.1038/s41388-021-01777-7